The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

which originally developed the drug, and Pfizer (NYSE:PFE). Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi (NASDAQ:SNY) all sold brand name Zantac ...

which originally developed the drug, and Pfizer. Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since ...

AIG has appointed Keith Walsh as Executive Vice President and Chief Financial Officer, effective October 21. Walsh brings ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...

A Chicago jury failed to reach a verdict in the latest Zantac cancer trial involving Boehringer Ingelheim. Plaintiff Ronald ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.